Paul Enever

Paul Enever co-founded Evidity Health Capital with Alejandro Sanchez in 2014.
He has been working in the healthcare industry with a focus on med tech for nearly 20 years.
Before joining Evidity, Paul was a partner at McKinsey and Company.
In his 12 years at McKinsey, he advised leading organizations across the biopharma, med tech, hospital, and healthcare services industries primarily in the U.S.
and Europe as well as private equity firms specializing in healthcare.
Paul’s work focused on growth strategy, sales and marketing, and licensing and acquisition.
Previously, Paul worked within the R&D organization at Sandoz Pharmaceuticals and MIT’s Biotechnology Process Engineering Center.
He sits on the Boards of Directors of Augmedics, Magnolia Medical Technologies, Poseidon Medical, and Standard Molecular.
Paul has a B.S.
in chemical engineering from Rensselaer Polytechnic Institute and a Ph.D.
in chemical engineering from the University of Minnesota where he studied wound healing and tissue engineering.
For his work, Paul was the recipient of both a National Science Foundation Graduate Fellowship and the Whitaker Foundation Graduate Fellowship in Biomedical Engineering.